Breaking News Instant updates and real-time market news.

2022-07-07 07:06:47 SSTK Shutterstock $59.37 / +0.35 (+0.59%) 07:06 07/07/22 07/07 07:06 07/07/22 07:06	Shutterstock joins the board of the News Media Coalition Shutterstock announced that it has joined the News Media Coalition, NMC, an international industry organization comprising global news brands, including major news publishers and news agencies. The membership marks a meaningful step for Shutterstock and its Editorial business. Shutterstock Editorial is committed to supporting a free press that allows journalists and contributors to report editorially on events around the world without arbitrary restriction. Additionally, the Editorial business has exclusive content partnerships with Conde Nast, 'epa', the LIFE Picture Collection, AP and A+E, as well as a significant presence at global events, including the English Premier League, the Screen Actors Guild Awards, the Academy Awards, the BAFTA's and more. Andrew Moger, Chief Executive Officer at News Media Coalition, said: "The NMC is the only international news industry body operating in this area. As we grow influence and success, we are delighted to have Shutterstock involved and supporting our mission. We know, like other major news brands in our membership, Shutterstock will bring a wealth of expertise and industry knowledge to the NMC. Shutterstock joins our board at a time when a free press is more important than ever. We look forward to working together on important policy issues, upholding and sharing our values of integrity and transparency and journalistic independence."	26 Jul

2022-07-07 07:06:47

SSTK

Shutterstock

$59.37 / +0.35 (+0.59%)

07:06

07/07/22

07/07

07:06

07/07/22

07:06

Shutterstock joins the board of the News Media Coalition

Shutterstock announced that it has joined the News Media Coalition, NMC, an international industry organization comprising global news brands, including major news publishers and news agencies. The membership marks a meaningful step for Shutterstock and its Editorial business. Shutterstock Editorial is committed to supporting a free press that allows journalists and contributors to report editorially on events around the world without arbitrary restriction. Additionally, the Editorial business has exclusive content partnerships with Conde Nast, 'epa', the LIFE Picture Collection, AP and A+E, as well as a significant presence at global events, including the English Premier League, the Screen Actors Guild Awards, the Academy Awards, the BAFTA's and more. Andrew Moger, Chief Executive Officer at News Media Coalition, said: "The NMC is the only international news industry body operating in this area. As we grow influence and success, we are delighted to have Shutterstock involved and supporting our mission. We know, like other major news brands in our membership, Shutterstock will bring a wealth of expertise and industry knowledge to the NMC. Shutterstock joins our board at a time when a free press is more important than ever. We look forward to working together on important policy issues, upholding and sharing our values of integrity and transparency and journalistic independence."

26
Jul

OTHER BREAKING NEWS FROM THE FLY

Recommendations	ShockWave Medical price target raised to $255 from $176 at Wells Fargo » 06:52 08/09/22 08/09 06:52 08/09/22 06:52 SWAV ShockWave Medical $221.92 / -0.94 (-0.42%) Wells Fargo analyst Larry… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in 9 minutes Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings On The Fly Events SWAV ShockWave Medical $221.92 / -0.94 (-0.42%) 06/21/22 ShockWave Medical to replace LiveRamp in S&P 400 at open on 6/21 06/03/22 ShockWave Medical to replace LiveRamp in S&P 400 at open on 6/21 05/23/22 ShockWave, Genesis obtain regulatory approval in China for Shockwave IVL System 05/19/22 ShockWave Medical announces long-term data from Disrupt PAD III trial SWAV ShockWave Medical $221.92 / -0.94 (-0.42%) 04:53 Today Piper Sandler ShockWave Medical price target raised to $278 from $245 at Piper Sandler 05/23/22 Piper Sandler ShockWave Medical's China approval adds growth driver, says Piper Sandler 05/10/22 Canaccord ShockWave Medical price target lowered to $190 from $221 at Canaccord 05/10/22 Wells Fargo ShockWave Medical price target lowered to $176 from $235 at Wells Fargo SWAV ShockWave Medical $221.92 / -0.94 (-0.42%) 08/08/22 ShockWave Medical raises FY22 revenue view to $465M-$475M from $435M-$455M 08/08/22 ShockWave Medical reports Q2 EPS 68c vs. (1c) last year 05/09/22 ShockWave Medical raises FY22 revenue view to $435M-$455M from $405-$425M 05/09/22 ShockWave Medical reports Q1 EPS 39c, consensus 18c SWAV ShockWave Medical $221.92 / -0.94 (-0.42%) 05/10/22 Fly Intel: Pre-market Movers 02/17/22 Fly Intel: After-Hours Movers 09/07/22 2022 Wells Fargo Healthcare Conference 11/07/22 ShockWave Medical - SWAV
Hot Stocks	Moderna amends Covid-19 vaccine agreement with EC » 06:52 08/09/22 08/09 06:52 08/09/22 06:52 MRNA Moderna $183.08 / -3.71 (-1.99%) Moderna announced an… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings Periodicals On The Fly Options MRNA Moderna $183.08 / -3.71 (-1.99%) 08/03/22 Moderna sees FY22 CapEx $600M-$800M 08/03/22 Moderna backs advance purchase agreements for expected delivery in 2022 of $21B 08/03/22 Moderna announces new $3B share repurchase plan 07/29/22 Moderna enters contract with U.S. government for 66M COVID-19 booster doses MRNA Moderna $183.08 / -3.71 (-1.99%) 06/29/22 Evercore ISI Icosavax upgraded to Outperform at Evercore on 'competitive' RSV vaccine data 06/14/22 Piper Sandler Piper Sandler confident in positive VRBPAC opinion for Moderna's SpikeVax 06/13/22 Morgan Stanley Moderna pediatric EUA vaccine briefing docs 'clean,' says Morgan Stanley 05/17/22 Piper Sandler Moderna price target lowered to $214 from $348 at Piper Sandler MRNA Moderna $183.08 / -3.71 (-1.99%) 08/03/22 Moderna reports Q2 GAAP EPS $5.24, consensus $4.55 05/04/22 Moderna reports Q1 GAAP EPS $8.58, consensus $5.21 05/03/22 Notable companies reporting before tomorrow's open 05/03/22 Notable companies reporting before tomorrow's open MRNA Moderna $183.08 / -3.71 (-1.99%) 06/28/22 FDA panel recommends omicron update for COVID vaccine boosters, CNBC says 06/23/22 Moderna vaccine for kids gets backing of CDC advisers, WSJ reports 06/15/22 Moderna to study COVID vaccine in babies as young as 3 months, WSJ says 06/02/22 Pfizer ask FDA to authorize three doses of vaccine for kids under 5, WSJ report MRNA Moderna $183.08 / -3.71 (-1.99%) 07/11/22 What You Missed On Wall Street On Monday 07/11/22 What You Missed On Wall Street This Morning 06/29/22 What You Missed On Wall Street On Wednesday 06/29/22 What You Missed On Wall Street This Morning MRNA Moderna $183.08 / -3.71 (-1.99%) 08/03/22 Early notable gainers among liquid option names on August 3rd 08/03/22 Unusually active option classes on open August 3rd 07/14/22 Moderna put volume heavy and directionally bearish 07/08/22 Early notable gainers among liquid option names on July 8th
Earnings	International Seaways reports Q2 adjusted EPS $1.43, consensus $1.19 » 06:51 08/09/22 08/09 06:51 08/09/22 06:51 INSW International Seaways $25.40 / +0.61 (+2.46%) Reports Q2 revenue… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in 9 minutes Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings On The Fly Events INSW International Seaways $25.40 / +0.61 (+2.46%) 07/06/22 International Seaways falls -11.8% 06/07/22 International Seaways board increases quarterly dividend 6c to 12c per share 06/07/22 International Seaways sells 50% stake in FSO vessels to Euronav 05/16/22 David Einhorn's Greenlight adds Southwestern, exits Sonos in Q1 INSW International Seaways $25.40 / +0.61 (+2.46%) 07/27/22 BTIG International Seaways upgraded to Buy from Neutral at BTIG 07/20/22 Jefferies International Seaways initiated with a Buy at Jefferies 07/19/22 Stifel International Seaways price target raised to $31 from $27 at Stifel 07/06/22 B. Riley Tanker stocks have more room to run, says B. Riley INSW International Seaways $25.40 / +0.61 (+2.46%) 05/04/22 International Seaways reports Q1 adjusted EPS (28c), consensus (31c) 03/02/22 International Seaways reports Q4 adjusted EPS (57c), consensus (36c) INSW International Seaways $25.40 / +0.61 (+2.46%) 07/27/22 Street Wrap: Today's Top 15 Upgrades, Downgrades, Initiations 04/22/22 Get Out Of These Stocks Now, POWR Ratings Algorithm Says 08/12/22 Annual Industrials, Energy & Airlines Conference 09:00 Today International Seaways - INSW
Downgrade	Global Blood Therapeutics downgraded to Equal Weight from Overweight at Wells Fargo » 06:50 08/09/22 08/09 06:50 08/09/22 06:50 GBT Global Blood Therapeutics $66.58 / +2.77 (+4.34%) , PFE Pfizer $49.55 / +0.29 (+0.59%) Wells Fargo analyst Jim… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings Periodicals On The Fly Events Options GBT PFE GBT Global Blood Therapeutics $66.58 / +2.77 (+4.34%) 08/08/22 Pfizer to acquire Global Blood Therapeutics for $68.50 per share in cash 08/08/22 Pfizer to acquire Global Blood Therapeutics for $68.50 per share in cash 08/05/22 Global Blood Therapeutics trading resumes 08/05/22 Fulcrum Therapeutics up 8% after WSJ says Pfizer in talks to buy Global Blood PFE Pfizer $49.55 / +0.29 (+0.59%) 08/08/22 Pfizer, Valneva initiate Phase 3 study of Lyme disease vaccine candidate VLA15 08/08/22 Pfizer to acquire Global Blood Therapeutics for $68.50 per share in cash 08/08/22 Pfizer to acquire Global Blood Therapeutics for $68.50 per share in cash 08/07/22 Myovant Sciences, Pfizer receive FDA approval of MYFEMBREE GBT PFE GBT Global Blood Therapeutics $66.58 / +2.77 (+4.34%) 08/08/22 Cantor Fitzgerald Global Blood downgraded to Neutral from Overweight at Cantor Fitzgerald 08/08/22 RBC Capital Global Blood downgraded to Sector Perform from Outperform at RBC Capital 08/08/22 Cowen Global Blood Therapeutics downgraded to Market Perform from Outperform at Cowen 08/08/22 Guggenheim Global Blood Therapeutics downgraded to Neutral from Buy at Guggenheim PFE Pfizer $49.55 / +0.29 (+0.59%) 08/08/22 Cantor Fitzgerald Global Blood downgraded to Neutral from Overweight at Cantor Fitzgerald 08/08/22 Oppenheimer Global Blood Therapeutics downgraded to Perform from Outperform at Oppenheimer 08/08/22 Stifel Global Blood Therapeutics downgraded to Hold from Buy at Stifel 08/08/22 Piper Sandler Global Blood takeover by Pfizer 'solid outcome,' says Piper Sandler GBT PFE GBT Global Blood Therapeutics $66.58 / +2.77 (+4.34%) 08/08/22 Notable companies reporting after market close 05/04/22 Global Blood Therapeutics reports Q1 EPS ($1.26), consensus ($1.30) 02/24/22 Global Blood Therapeutics reports Q4 EPS ($1.36), consensus ($1.13) PFE Pfizer $49.55 / +0.29 (+0.59%) 07/28/22 Pfizer raises FY22 adjusted EPS view to $6.30-$6.45 from $6.25-$6.45 07/28/22 Pfizer reports Q2 adjusted EPS $2.04, consensus $1.80 07/27/22 Notable companies reporting before tomorrow's open 07/27/22 Notable companies reporting before tomorrow's open GBT PFE GBT Global Blood Therapeutics $66.58 / +2.77 (+4.34%) 08/05/22 Pfizer in advanced talks to buy Global Blood for about $5B, WSJ reports 08/05/22 Pfizer in talks to buy Global Blood Therapeutics for about $5B, WSJ says PFE Pfizer $49.55 / +0.29 (+0.59%) 08/05/22 Pfizer in advanced talks to buy Global Blood for about $5B, WSJ reports 08/05/22 Pfizer in talks to buy Global Blood Therapeutics for about $5B, WSJ says 07/18/22 GSK CEO says split will help deal with 'perennial underperformance,' FT reports 06/28/22 FDA panel recommends omicron update for COVID vaccine boosters, CNBC says GBT PFE GBT Global Blood Therapeutics $66.58 / +2.77 (+4.34%) 08/08/22 What You Missed On Wall Street On Monday 08/08/22 What You Missed On Wall Street This Morning 08/08/22 Fly Intel: Pre-market Movers 08/05/22 What You Missed On Wall Street On Friday PFE Pfizer $49.55 / +0.29 (+0.59%) 08/08/22 What You Missed On Wall Street On Monday 08/08/22 What You Missed On Wall Street This Morning 08/08/22 Fly Intel: Pre-market Movers 08/05/22 What You Missed On Wall Street On Friday 09/10/22 ESMO Congress 2022 08/30/22 Global Blood Therapeutics PFE PFE Pfizer $49.55 / +0.29 (+0.59%) 07/28/22 Unusually active option classes on open July 28th 06/30/22 Early notable gainers among liquid option names on June 30th 05/20/22 Early notable gainers among liquid option names on May 20th 04/26/22 Unusually active option classes on open April 26th
Earnings	IAA reports Q2 adjusted EPS 62c, consensus 57c » 06:50 08/09/22 08/09 06:50 08/09/22 06:50 IAA IAA $38.26 / +0.54 (+1.43%) Reports Q2 revenue… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in 9 minutes Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings Events IAA IAA $38.26 / +0.54 (+1.43%) 07/28/22 IAA opens new Hawaii branch 06/09/22 IAA announces opening of Bristol branch in the UK 05/25/22 IAA expands, relocates UK head office 03/30/22 IAA expands capacity in Iowa, Illinois IAA IAA $38.26 / +0.54 (+1.43%) 06/09/22 Guggenheim IAA upgraded to Buy from Neutral at Guggenheim 05/10/22 Barrington IAA upgraded to Outperform at Barrington after better-than-expected Q1 05/10/22 Barrington IAA upgraded to Outperform from Market Perform at Barrington 03/15/22 Stephens Stephens agrees with activist that IAA undervalued IAA IAA $38.26 / +0.54 (+1.43%) 05/10/22 IAA cuts FY22 revenue view to $2B-$2.1B from $2.05B-$2.15B, consensus $2.09B 05/10/22 IAA reports Q1 adjusted EPS 66c, consensus 58c 02/11/22 IAA sees FY22 revenue $2.05B-$2.15B, consensus $1.96B 02/11/22 IAA reports Q4 adjusted EPS 61c, consensus 52c 09:00 Today IAA - IAA
Earnings	Target Hospitality reports Q2 EPS 24c, consensus 17c » 06:49 08/09/22 08/09 06:49 08/09/22 06:49 TH Target Hospitality $13.97 / +0.12 (+0.87%) Reports Q2 revenue… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings On The Fly Events TH Target Hospitality $13.97 / +0.12 (+0.87%) 07/07/22 Target Hospitality announces expanded humanitarian contract 05/25/22 Target Hospitality CEO Brad Archer to remain in position through 2025 03/29/22 Target Hospitality Corp trading resumes 03/29/22 Target Hospitality Corp trading halted, volatility trading pause TH Target Hospitality $13.97 / +0.12 (+0.87%) 07/12/22 Oppenheimer Target Hospitality price target raised to $18 from $9 at Oppenheimer TH Target Hospitality $13.97 / +0.12 (+0.87%) 07/08/22 Target Hospitality raises FY22 revenue view to $500M-$510M from $325M-$335M 07/08/22 Target Hospitality sees Q2 revenue $102M-$107M, consensus $82.67M 05/10/22 Target Hospitality sees FY22 revenue $325M-$335M, consensus $332.1M 05/10/22 Target Hospitality reports Q1 EPS 1c, consensus 1c TH Target Hospitality $13.97 / +0.12 (+0.87%) 07/08/22 What You Missed On Wall Street On Friday 07/08/22 What You Missed On Wall Street This Morning 07/08/22 Fly Intel: Pre-market Movers 09:00 Today Target Hospitality - TH 09/13/22 Target Hospitality 09/14/22 Target Hospitality
Recommendations	Enanta price target raised to $137 from $103 at JMP Securities » 06:49 08/09/22 08/09 06:49 08/09/22 06:49 ENTA Enanta $71.21 / +0.39 (+0.55%) JMP Securities analyst… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in 9 minutes Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings On The Fly ENTA Enanta $71.21 / +0.39 (+0.55%) 07/29/22 Enanta announces data from Phase 1 study of EDP-235 06/21/22 Enanta files patent infringement lawsuit against Pfizer 05/18/22 Enanta falls 13% after announcing EDP-938 did not meet primary endpoint 05/18/22 Enanta says EDP-938 did not meet primary endpoint in RSVP study ENTA Enanta $71.21 / +0.39 (+0.55%) 08/01/22 Oppenheimer Enanta price target raised to $53 from $45 at Oppenheimer 07/29/22 Piper Sandler Enanta's 'strong' EDP-235 data supports 'impressive' profile, says Piper Sandler 07/06/22 Evercore ISI Enanta upgraded to Outperform at Evercore ISI ahead of COVID anti-viral data 07/06/22 Evercore ISI Enanta upgraded to Outperform from In Line at Evercore ISI ENTA Enanta $71.21 / +0.39 (+0.55%) 08/08/22 Enanta reports Q3 EPS ($1.53), consensus ($1.39) 05/09/22 Enanta reports Q2 EPS ($1.63), consensus ($1.43) ENTA Enanta $71.21 / +0.39 (+0.55%) 07/06/22 What You Missed On Wall Street On Wednesday 07/06/22 What You Missed On Wall Street This Morning 07/06/22 Street Wrap: Today's Top 15 Upgrades, Downgrades, Initiations 05/18/22 Fly Intel: After-Hours Movers
Earnings	Capri Holdings sees FY23 EPS $6.85, consensus $6.74 » 06:49 08/09/22 08/09 06:49 08/09/22 06:49 CPRI Capri Holdings $51.01 / +1.38 (+2.78%) Sees FY23 revenue… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings On The Fly Events Options CPRI Capri Holdings $51.01 / +1.38 (+2.78%) 07/20/22 Capri Holdings sees forex headwinds of $300M in FY23 07/20/22 Capri Holdings interested in 'fashion luxury' acquisitions 07/20/22 Capri Holdings targets long-term operating margin about 20% 07/20/22 Capri Holdings up 2% as revenue targets discussed during investor day CPRI Capri Holdings $51.01 / +1.38 (+2.78%) 07/28/22 Barclays Capri Holdings price target raised to $66 from $63 at Barclays 07/21/22 Credit Suisse Capri Holdings price target lowered to $56 from $65 at Credit Suisse 07/21/22 Goldman Sachs Capri Holdings price target lowered to $59 from $69 at Goldman Sachs 07/15/22 UBS Capri Holdings price target lowered to $65 from $91 at UBS CPRI Capri Holdings $51.01 / +1.38 (+2.78%) 06:47 Today Capri Holdings reports Q1 adjusted EPS $1.50, consensus $1.36 07/20/22 Capri Holdings backs FY23 EPS view $6.85, consensus $6.83 06/01/22 Capri Holdings provides quarterly FY23 guidance 06/01/22 Capri Holdings sees Q1 EPS $1.35, consensus $1.45 CPRI Capri Holdings $51.01 / +1.38 (+2.78%) 07/20/22 What You Missed On Wall Street On Wednesday 07/20/22 What You Missed On Wall Street This Morning 06/01/22 What You Missed On Wall Street On Wednesday 06/01/22 What You Missed On Wall Street This Morning 08:30 Today Capri Holdings - CPRI CPRI Capri Holdings $51.01 / +1.38 (+2.78%) 07/25/22 Largest borrow rate increases among liquid names 06/30/22 Capri Holdings call volume above normal and directionally bullish 06/16/22 Capri Holdings call volume above normal and directionally bullish 06/13/22 Capri Holdings call volume above normal and directionally bullish
Recommendations	Tyson Foods price target lowered to $95 from $100 at Stephens » 06:49 08/09/22 08/09 06:49 08/09/22 06:49 TSN Tyson Foods $80.10 / -7.395 (-8.45%) Stephens analyst Ben… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in 9 minutes Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings Periodicals On The Fly Options TSN Tyson Foods $80.10 / -7.395 (-8.45%) 08/08/22 Tyson Foods: Demand for chicken 'extremely strong' 08/08/22 Tyson: Prepared fods unit can't fulfill all orders due to supply constraints 08/08/22 Tyson Foods CEO says demand 'relatively steady' 08/08/22 Tyson Foods focused on overcoming supply chain challenges, says CEO TSN Tyson Foods $80.10 / -7.395 (-8.45%) 06:16 Today BMO Capital Tyson Foods price target lowered to $90 from $99 at BMO Capital 05:55 Today Barclays Tyson Foods price target lowered to $89 from $100 at Barclays 04:57 Today Piper Sandler Piper upgrades Tyson Foods to Neutral with risks priced in 08/08/22 Piper Sandler Tyson Foods upgraded to Neutral from Underweight at Piper Sandler TSN Tyson Foods $80.10 / -7.395 (-8.45%) 08/08/22 Tyson Foods sees 2022 revenue $52B-$54B, consensus $52.8B 08/08/22 Tyson Foods reports Q3 adjusted EPS $1.94 vs. $2.70 last year 07/06/22 Tyson Foods buys strategic stake in Tanmiah of Saudi Arabia 05/09/22 Tyson Foods raises FY22 revenue view to $52B-$54B from $49B-$51B TSN Tyson Foods $80.10 / -7.395 (-8.45%) 08/03/22 NY AG says Tyson ignoring subpoena for meat price investigation, Reuters says 07/11/22 Tyson Foods works to fix operations as it falls behind competitors, WSJ reports 02/15/22 Tyson Foods to ease mask rules at some processing plants, NY Times reports TSN Tyson Foods $80.10 / -7.395 (-8.45%) 08/08/22 What You Missed On Wall Street On Monday 08/08/22 What You Missed On Wall Street This Morning 08/08/22 Fly Intel: Pre-market Movers 07/11/22 What You Missed On Wall Street On Monday TSN Tyson Foods $80.10 / -7.395 (-8.45%) 08/08/22 Unusually active option classes on open August 8th 03/14/22 Unusually active option classes on open March 14th 03/04/22 Tyson Foods put volume heavy and directionally bearish 03/02/22 Unusually active option classes on open March 2nd
Recommendations	Reata Pharmaceuticals price target lowered to $27 from $37 at Baird » 06:49 08/09/22 08/09 06:49 08/09/22 06:49 RETA Reata Pharmaceuticals $24.02 / -11.895 (-33.12%) Baird analyst Brian… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings On The Fly Events RETA Reata Pharmaceuticals $24.02 / -11.895 (-33.12%) 08/08/22 Reata CEO looks forward to working with FDA on review of omaveloxone NDA 08/08/22 Reata Pharmaceuticals trading resumes 08/08/22 Reata Pharmaceuticals trading halted, volatility trading pause 05/26/22 Reata Pharmaceuticals' NDA for omaveloxolone granted Priority Review by FDA RETA Reata Pharmaceuticals $24.02 / -11.895 (-33.12%) 08/08/22 Goldman Sachs Reata sinks on Friedreich's ataxia update but Goldman remains positive 08/08/22 Goldman Sachs Reata Pharmaceuticals price target raised to $76 from $73 at Goldman Sachs 05/27/22 Citi Reata Pharmaceuticals price target raised to $46 from $43 at Citi 05/11/22 Ladenburg Reata Pharmaceuticals price target lowered to $67 from $75 at Ladenburg RETA Reata Pharmaceuticals $24.02 / -11.895 (-33.12%) 08/08/22 Reata Pharmaceuticals reports Q2 EPS ($2.02) , consensus ($2.02) 05/10/22 Reata Pharmaceuticals reports Q1 adjusted EPS ($1.33), consensus ($2.15) 02/28/22 Reata Pharmaceuticals reports Q4 EPS ($2.35), consensus ($2.31) RETA Reata Pharmaceuticals $24.02 / -11.895 (-33.12%) 08/08/22 What You Missed On Wall Street On Monday 08/08/22 What You Missed On Wall Street This Morning 02/28/22 What You Missed On Wall Street This Morning 11/30/22 PDUFA Date for Omaveloxolone

Hot Stocks	Wireless Telecom sees Q3 bookings $8M-$10M » 06:48 08/09/22 08/09 06:48 08/09/22 06:48 WTT Wireless Telecom $1.56 / +0.08 (+5.41%) Tim Whelan, CEO of… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in 9 minutes Get Free Trial ShowHide Related Items >><< Company News Earnings Events WTT Wireless Telecom $1.56 / +0.08 (+5.41%) 07/25/22 CommAgility introduces 5G Network Listening Mode software 06/21/22 Wireless Telecom's Noisecom introduces 60 GHz jitter noise generator 06/15/22 Wireless Telecom to showcase specialized solutions at IMS 2022 05/26/22 Wireless Telecom's Boonton introduces NGX1000 Programmable Noise Generator WTT Wireless Telecom $1.56 / +0.08 (+5.41%) 06:46 Today Wireless Telecom reports Q2 cont ops EPS (6c), consensus (4c) 03/17/22 Wireless Telecom reports Q4 EPS 2c vs. (25c) a year ago 02/10/22 Wireless Telecom sees Q4 revenue $13.1M, consensus $13.39M 08:30 Today Wireless Telecom - WTT
Earnings	Capri Holdings reports Q1 adjusted EPS $1.50, consensus $1.36 » 06:47 08/09/22 08/09 06:47 08/09/22 06:47 CPRI Capri Holdings $51.01 / +1.38 (+2.78%) Reports Q1 revenue… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings On The Fly Events Options CPRI Capri Holdings $51.01 / +1.38 (+2.78%) 07/20/22 Capri Holdings sees forex headwinds of $300M in FY23 07/20/22 Capri Holdings interested in 'fashion luxury' acquisitions 07/20/22 Capri Holdings targets long-term operating margin about 20% 07/20/22 Capri Holdings up 2% as revenue targets discussed during investor day CPRI Capri Holdings $51.01 / +1.38 (+2.78%) 07/28/22 Barclays Capri Holdings price target raised to $66 from $63 at Barclays 07/21/22 Credit Suisse Capri Holdings price target lowered to $56 from $65 at Credit Suisse 07/21/22 Goldman Sachs Capri Holdings price target lowered to $59 from $69 at Goldman Sachs 07/15/22 UBS Capri Holdings price target lowered to $65 from $91 at UBS CPRI Capri Holdings $51.01 / +1.38 (+2.78%) 07/20/22 Capri Holdings backs FY23 EPS view $6.85, consensus $6.83 06/01/22 Capri Holdings provides quarterly FY23 guidance 06/01/22 Capri Holdings sees Q1 EPS $1.35, consensus $1.45 06/01/22 Capri Holdings sees FY23 EPS $6.85, consensus $6.57 CPRI Capri Holdings $51.01 / +1.38 (+2.78%) 07/20/22 What You Missed On Wall Street On Wednesday 07/20/22 What You Missed On Wall Street This Morning 06/01/22 What You Missed On Wall Street On Wednesday 06/01/22 What You Missed On Wall Street This Morning 08:30 Today Capri Holdings - CPRI CPRI Capri Holdings $51.01 / +1.38 (+2.78%) 07/25/22 Largest borrow rate increases among liquid names 06/30/22 Capri Holdings call volume above normal and directionally bullish 06/16/22 Capri Holdings call volume above normal and directionally bullish 06/13/22 Capri Holdings call volume above normal and directionally bullish
Hot Stocks	Planet Fitness announces Jamie Medeiros as chief brand officer » 06:47 08/09/22 08/09 06:47 08/09/22 06:47 PLNT Planet Fitness $81.08 / +0.71 (+0.88%) Planet Fitness announced… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in 9 minutes Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings On The Fly Events PLNT Planet Fitness $81.08 / +0.71 (+0.88%) 05/25/22 Blue Apron adds partnerships with Blue Cross Blue Shield, Planet Fitness 05/10/22 Planet Fitness announces development agreement in New Zealand PLNT Planet Fitness $81.08 / +0.71 (+0.88%) 07/07/22 Exane BNP Paribas Planet Fitness upgraded to Neutral from Underperform at Exane BNP Paribas 06/13/22 Jefferies Jefferies names five top picks in lifestyle and growth platforms 06/07/22 Cowen Planet Fitness positioned to succeed despite macro challenges, says Cowen 05/25/22 Cowen Planet Fitness operating model remains resilient among headwinds, says Cowen PLNT Planet Fitness $81.08 / +0.71 (+0.88%) 06:40 Today Planet Fitness sees FY22 adjusted EPS up mid-80% range 06:37 Today Planet Fitness reports Q2 adjusted EPS 38c vs. 21c last year 05/10/22 Planet Fitness sees 2022 revenue increasing in mid-50 percent range 05/10/22 Planet Fitness reports Q1 adjusted EPS 32c, consensus 27c PLNT Planet Fitness $81.08 / +0.71 (+0.88%) 07/07/22 Street Wrap: Today's Top 15 Upgrades, Downgrades, Initiations 05/11/22 What You Missed On Wall Street On Wednesday 05/11/22 What You Missed On Wall Street This Morning 05/11/22 Street Wrap: Today's Top 15 Upgrades, Downgrades, Initiations 08:00 Today Planet Fitness - PLNT
Recommendations	Mersana Therapeutics price target raised to $20 from $18 at Baird » 06:47 08/09/22 08/09 06:47 08/09/22 06:47 MRSN Mersana Therapeutics $5.24 / +0.215 (+4.28%) , GSK GSK plc $40.31 / -0.27 (-0.67%) Baird analyst Collen Kusy… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings Periodicals On The Fly Events Options MRSN GSK MRSN Mersana Therapeutics $5.24 / +0.215 (+4.28%) 08/08/22 Mersana to get $100M upfront fee from GSK for co-commercialization of XMT-2056 08/08/22 Mersana Therapeutics trading resumes 08/08/22 Mersana Therapeutics trading halted, news pending 05/23/22 Mersana Therapeutics director Hack buys 216K shares of stock GSK GSK plc $40.31 / -0.27 (-0.67%) 08/08/22 Mersana to get $100M upfront fee from GSK for co-commercialization of XMT-2056 08/08/22 GSK, IQVIA launch Vaccine Track platform 07/29/22 ViiV Healthcare presents five-year data at AIDS 2022 on fostemsavir 07/28/22 ViiV Healthcare announces data from unblinded phase of HPTN 084 study MRSN GSK MRSN Mersana Therapeutics $5.24 / +0.215 (+4.28%) 05/10/22 Baird Mersana Therapeutics price target lowered to $18 from $23 at Baird 05/09/22 H.C. Wainwright Mersana price target lowered to $19 from $24 at H.C. Wainwright 11/10/21 Baird Mersana Therapeutics price target lowered to $23 from $30 at Baird 10/14/21 BTIG Mersana Therapeutics assumed with a Buy at BTIG GSK GSK plc $40.31 / -0.27 (-0.67%) 08/08/22 UBS GSK plc price target lowered to 1,820 GBp from 1,860 GBp at UBS 08/05/22 Morgan Stanley GSK plc resumed with an Equal Weight at Morgan Stanley 07/21/22 Citi GSK plc resumed with a Neutral at Citi 07/20/22 UBS GSK plc price target lowered to 1,850 GBp from 1,876 GBp at UBS MRSN GSK MRSN Mersana Therapeutics $5.24 / +0.215 (+4.28%) 08/08/22 Mersana Therapeutics reports Q2 EPS (55c), consensus (52c) 05/09/22 Mersana Therapeutics reports Q1 EPS (59c), consensus (32c) 02/28/22 Mersana Therapeutics reports Q4 EPS (68c), consensus (67c) GSK GSK plc $40.31 / -0.27 (-0.67%) 07/27/22 GSK plc reports Q2 adjusted EPS 34.7p vs. 28.2p last year 04/27/22 GlaxoSmithKline reaffirms FY22 sales growth between 5%-7% at CER 04/27/22 GlaxoSmithKline reports Q1 adjusted EPS 32.8p vs. 22.9p last year 04/13/22 GlaxoSmithKline backs FY22 revenue view up 5%-7% at CER, consensus $47.34B GSK GSK GSK plc $40.31 / -0.27 (-0.67%) 07/18/22 GSK CEO says split will help deal with 'perennial underperformance,' FT reports 06/27/22 GSK's Haleon chooses Citi, UBS as spinoff brokers, Bloomberg says 06/27/22 GSK's Haleon chooses Citi, UBS as spinoff brokers, Bloomberg says 06/06/22 GSK rectal cancer trial yields remission in all 18 patients, NY Times reports MRSN GSK MRSN Mersana Therapeutics $5.24 / +0.215 (+4.28%) 08/08/22 Fly Intel: After-Hours Movers 04/14/22 What You Missed On Wall Street This Morning 02/09/22 Wall Street in Fives - Must Read Lists for Wednesday 02/09/22 Wall Street in Fives - Must Read Lists at Midday GSK GSK plc $40.31 / -0.27 (-0.67%) 08/05/22 Street Wrap: Today's Top 15 Upgrades, Downgrades, Initiations 07/18/22 What You Missed On Wall Street This Morning 07/18/22 Fly Intel: Pre-market Movers 06/24/22 What You Missed On Wall Street On Friday 06/08/22 Global Healthcare Conference 00:00 Today Wedbush PacGrow Healthcare Virtual Conference 09/10/22 ESMO Congress 2022 GSK GSK GSK plc $40.31 / -0.27 (-0.67%) 07/29/22 GSK plc (ADR) call volume above normal and directionally bullish 07/22/22 Two new option listings and one option delisting on July 22nd 07/20/22 One new option listing and two option delistings on July 20th 07/08/22 GlaxoSmithKline call volume above normal and directionally bullish
Earnings	Wireless Telecom reports Q2 cont ops EPS (6c), consensus (4c) » 06:46 08/09/22 08/09 06:46 08/09/22 06:46 WTT Wireless Telecom $1.56 / +0.08 (+5.41%) Reports Q2 revenue $6.1M,… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in 9 minutes Get Free Trial ShowHide Related Items >><< Company News Earnings Events WTT Wireless Telecom $1.56 / +0.08 (+5.41%) 07/25/22 CommAgility introduces 5G Network Listening Mode software 06/21/22 Wireless Telecom's Noisecom introduces 60 GHz jitter noise generator 06/15/22 Wireless Telecom to showcase specialized solutions at IMS 2022 05/26/22 Wireless Telecom's Boonton introduces NGX1000 Programmable Noise Generator WTT Wireless Telecom $1.56 / +0.08 (+5.41%) 03/17/22 Wireless Telecom reports Q4 EPS 2c vs. (25c) a year ago 02/10/22 Wireless Telecom sees Q4 revenue $13.1M, consensus $13.39M 08:30 Today Wireless Telecom - WTT
Recommendations	Scholar Rock price target lowered to $43 from $55 at BMO Capital » 06:46 08/09/22 08/09 06:46 08/09/22 06:46 SRRK Scholar Rock $8.54 / +0.035 (+0.41%) BMO Capital analyst Gary… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings Events SRRK Scholar Rock $8.54 / +0.035 (+0.41%) 06/17/22 Scholar Rock announces new data from TOPAZ trial extension period 05/16/22 Scholar Rock announces 25% workforce reduction 05/16/22 Scholar Rock Chief Medical Officer to step down SRRK Scholar Rock $8.54 / +0.035 (+0.41%) 07/12/22 Truist Scholar Rock initiated with a Buy at Truist 06/23/22 Piper Sandler Scholar Rock price target lowered to $19 from $28 at Piper Sandler 05/24/22 JPMorgan Scholar Rock price target lowered to $37 from $46 at JPMorgan 05/17/22 BMO Capital Scholar Rock price target lowered to $55 from $74 at BMO Capital SRRK Scholar Rock $8.54 / +0.035 (+0.41%) 08/08/22 Scholar Rock reports Q2 EPS ($1.06), consensus ($1.03) 05/16/22 Scholar Rock reports Q1 EPS (21c), consensus (62c) 03/07/22 Scholar Rock reports FY21 EPS ($3.59), consensus ($3.67) 00:00 Today Wedbush PacGrow Healthcare Virtual Conference
Hot Stocks	Hormel Foods announces new operating model » 06:46 08/09/22 08/09 06:46 08/09/22 06:46 HRL Hormel Foods $49.03 / +0.105 (+0.21%) Hormel Foods announced a… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in 9 minutes Get Free Trial ShowHide Related Items >><< Street Research Earnings On The Fly Events Options HRL Hormel Foods $49.03 / +0.105 (+0.21%) 03/15/22 Goldman Sachs Hormel Foods downgraded to Sell from Neutral at Goldman Sachs 03/10/22 Argus Hormel Foods upgraded to Buy at Argus on pricing power 03/10/22 Argus Hormel Foods upgraded to Buy from Hold at Argus 01/25/22 Piper Sandler Hormel Foods price target lowered to $48 from $49 at Piper Sandler HRL Hormel Foods $49.03 / +0.105 (+0.21%) 06/02/22 Hormel Foods cuts FY22 EPS view to $1.87-$1.97 from $1.87-$2.03 06/02/22 Hormel Foods reports Q2 EPS 48c, consensus 47c 06/01/22 Notable companies reporting before tomorrow's open 06/01/22 Notable companies reporting before tomorrow's open HRL Hormel Foods $49.03 / +0.105 (+0.21%) 06/02/22 What You Missed On Wall Street On Thursday 06/02/22 What You Missed On Wall Street This Morning 03/15/22 What You Missed On Wall Street On Tuesday 03/15/22 What You Missed On Wall Street This Morning 09/01/22 Hormel Foods - HRL HRL Hormel Foods $49.03 / +0.105 (+0.21%) 03/01/22 Early notable gainers among liquid option names on March 1st
Downgrade	Nike downgraded to Neutral at Exane BNP Paribas on concerns about FY25 targets » 06:44 08/09/22 08/09 06:44 08/09/22 06:44 NKE Nike $114.01 / +0.13 (+0.11%) Exane BNP Paribas analyst… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings Periodicals On The Fly Events Options NKE Nike $114.01 / +0.13 (+0.11%) 07/27/22 CarGurus appoints Javier Zamora as general counsel 07/19/22 Skechers down 4% as short-seller Spruce Point sees 30%-50% downside risk 06/27/22 Nike says taking 'cautious approach' to greater China in FY23 06/27/22 Nike says digital now represents 24% of brand revenue NKE Nike $114.01 / +0.13 (+0.11%) 05:30 Today Exane BNP Paribas Nike downgraded to Neutral from Outperform at Exane BNP Paribas 07/25/22 Piper Sandler Nike assumed with a Neutral at Piper Sandler 07/21/22 KeyBanc KeyBanc transitions coverage of Global Brands & E-Commerce with cautious view 07/20/22 KeyBanc Nike initiated with a Sector Weight at KeyBanc NKE Nike $114.01 / +0.13 (+0.11%) 06/27/22 Nike sees Q1 revenue growth flat to slightly up sequentially, consensus $12.88B 06/27/22 Nike sees FY23 revenue growth in low double digits, consensus $51.57B 06/27/22 Nike reports Q4 EPS 90c, consensus 81c 06/27/22 Notable companies reporting after market close NKE Nike $114.01 / +0.13 (+0.11%) 06/23/22 Cisco, Nike planning to fully exit Russia, Reuters reports 05/24/22 Nike not renewing franchise deal with IRG, will leave Russia, Vedomosti says 05/18/22 Nike's head of diversity to leave at end of July, FT reports 03/19/22 Nike reports earnings Monday, investors shouldn't get hopes up, Barron's says NKE Nike $114.01 / +0.13 (+0.11%) 07/11/22 Game On: Wedbush's Pachter calls GameStop chairman 'deluded' 06/28/22 What You Missed On Wall Street On Tuesday 06/28/22 What You Missed On Wall Street This Morning 06/28/22 Fly Intel: Pre-market Movers 09/09/22 Nike Inc. NKE Nike $114.01 / +0.13 (+0.11%) 07/05/22 Early notable gainers among liquid option names on July 5th 06/29/22 Early notable gainers among liquid option names on June 29th 06/27/22 Nike options imply 8.0% move in share price post-earnings 06/27/22 Unusually active option classes on open June 27th
Earnings	Vivid Seats raises FY22 revenue view to $540.0M-$570.0M from $520.0M-$555.0M » 06:44 08/09/22 08/09 06:44 08/09/22 06:44 SEAT Vivid Seats $8.70 / +0.18 (+2.11%) Consensus is for FY22… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in 9 minutes Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings Events SEAT Vivid Seats $8.70 / +0.18 (+2.11%) 07/27/22 Vivid Seats, Rolling Stone announce a multi-faceted partnership 06/30/22 Vivid Seats announces expiration, results of exchange offer 06/16/22 Vivid Seats to join Russell 2000, Russell 3000 Indexes 05/26/22 Vivid Seats board authorizes $40M share repurchase program SEAT Vivid Seats $8.70 / +0.18 (+2.11%) 07/14/22 Piper Sandler Vivid Seats initiated with a Neutral at Piper Sandler 07/07/22 Citi Vivid Seats price target lowered to $12 from $14 at Citi 05/10/22 Raymond James Vivid Seats price target lowered to $11 from $17 at Raymond James 03/11/22 Benchmark Vivid Seats price target lowered to $17 from $19 at Benchmark SEAT Vivid Seats $8.70 / +0.18 (+2.11%) 06:42 Today Vivid Seats reports Q2 rvenue $147.7M, consensus $125.4M 05/10/22 Vivid Seats raises FY22 revenue view to $520.0M-$555.0M from $510.0M-$550.0M 05/10/22 Vivid Seats reports Q1 revenue $130.8M, consensus $113.83M 03/10/22 Vivid Seats sees 2022 revenue $510M-$550M, consensus $554.44M 08/08/22 42nd Annual Global I Growth Conference 09/08/22 Consumer/Media/Entertainment Conference 08:30 Today Vivid Seats - SEAT
Recommendations	Castle Biosciences price target raised to $48 from $44 at Baird » 06:44 08/09/22 08/09 06:44 08/09/22 06:44 CSTL Castle Biosciences $28.33 / -2.34 (-7.63%) Baird analyst Catherine… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings On The Fly Events CSTL Castle Biosciences $28.33 / -2.34 (-7.63%) 07/25/22 Castle Biosciences announces DecisionDx-Melanoma surpasses 100,000 tests ordered 06/22/22 Castle Biosciences announces data showing value of skin cancer tests 05/24/22 Castle Biosciences announces results from TissueCypher Barrett's Esophagus study 05/19/22 Castle Biosciences' DecisionDx-SCC shows risk-stratification efficacy in study CSTL Castle Biosciences $28.33 / -2.34 (-7.63%) 05/19/22 Baird Baird says final LCD for test 'incrementally positive' for Castle Biosciences 05/10/22 Canaccord Castle Biosciences price target lowered to $65 from $80 at Canaccord 05/10/22 Baird Castle Biosciences price target lowered to $44 from $50 at Baird 05/09/22 BTIG Castle Biosciences transferred with a Buy at BTIG CSTL Castle Biosciences $28.33 / -2.34 (-7.63%) 08/08/22 Castle Biosciences raises FY22 revenue view to $130M-$135M from $118M-$123M 08/08/22 Castle Biosciences reports Q2 EPS (6c), consensus (76c) 05/09/22 Castle Biosciences raises FY22 revenue view to $118M-$123M from $115M-$120M 05/09/22 Castle Biosciences reports Q1 EPS (97c), consensus (71c) CSTL Castle Biosciences $28.33 / -2.34 (-7.63%) 04/04/22 Fly Intel: After-Hours Movers 08/08/22 42nd Annual Global I Growth Conference 09/14/22 6th Annual Best Ideas Growth Conference: Big 6

Hot Stocks	Nielsen postpones court, special meeting regarding acquisition by consortium » 06:43 08/09/22 08/09 06:43 08/09/22 06:43 NLSN Nielsen $22.71 / -0.33 (-1.43%) Nielsen announced that… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in 9 minutes Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings Periodicals On The Fly Events Options NLSN Nielsen $22.71 / -0.33 (-1.43%) 07/29/22 Nielsen receives regulatory approval for proposed transaction 07/25/22 ISS recommends Nielsen holders vote 'FOR' proposed transaction 06/16/22 Magnite expands measurement, attribution program for currency optionality 05/16/22 Elliott adds Diamond Offshore, exits Arconic in Q1 NLSN Nielsen $22.71 / -0.33 (-1.43%) 05/16/22 BMO Capital Nielsen downgraded to Market Perform from Outperform at BMO Capital 03/30/22 Jefferies Nielsen downgraded to Hold from Buy at Jefferies 03/29/22 Morgan Stanley Morgan Stanley raises Nielsen to Equal Weight, says 'may be better off private' 03/29/22 Morgan Stanley Nielsen upgraded to Equal Weight from Underweight at Morgan Stanley NLSN Nielsen $22.71 / -0.33 (-1.43%) 07/27/22 Nielsen backs FY22 adjusted EPS $1.81-$1.91, consensus $1.88 07/27/22 Nielsen reports Q2 adjusted EPS 46c, consensus 43c 04/28/22 Nielsen backs FY22 adjusted EPS $1.81-$1.91, consensus $1.83 04/28/22 Nielsen reports Q1 adjusted EPS 45c, consensus 40c NLSN Nielsen $22.71 / -0.33 (-1.43%) 04/22/22 U.K. probing WindAcre stake in Nielsen, Bloomberg reports 04/07/22 WindAcre offer to support Nielsen buyout quickly rejected, Bloomberg says 03/22/22 Elliott, Brookfield mull raising offer for Nielsen, Bloomberg reports 03/22/22 Elliott, Brookfield mull raising offer for Nielsen, Bloomberg reports NLSN Nielsen $22.71 / -0.33 (-1.43%) 05/16/22 Street Wrap: Today's Top 15 Upgrades, Downgrades, Initiations 03/30/22 Street Wrap: Today's Top 15 Upgrades, Downgrades, Initiations 03/29/22 What You Missed On Wall Street On Tuesday 03/29/22 What You Missed On Wall Street This Morning 08:15 Today Nielsen Holdings plc NLSN Nielsen $22.71 / -0.33 (-1.43%) 03/29/22 Early notable gainers among liquid option names on March 29th 03/22/22 Nielsen call volume above normal and directionally bullish
Earnings	Hain Celestial sees FY23 low single digit adjusted net sales growth » 06:43 08/09/22 08/09 06:43 08/09/22 06:43 HAIN Hain Celestial $23.08 / +0.1 (+0.44%) FY23 outlook: The company… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Street Research Earnings Syndicate HAIN Hain Celestial $23.08 / +0.1 (+0.44%) 06/16/22 Piper Sandler Hain Celestial price target lowered to $31 from $36 at Piper Sandler 05/24/22 CL King Hain Celestial initiated with a Buy at CL King 05/23/22 Cowen Hain Celestial initiated with an Outperform at Cowen 05/09/22 Mizuho Hain Celestial price target lowered to $31 from $44 at Mizuho HAIN Hain Celestial $23.08 / +0.1 (+0.44%) 06:41 Today Hain Celestial sees Q4 revenue approximately $457M, consensus $478.45M 05/05/22 Hain Celestial sees 2022 flat adjusted net sales, consensus $1.95B 05/05/22 Hain Celestial sees Q4 low to mid single digital adjusted net sales growth 05/05/22 Hain Celestial reports Q3 adjusted EPS 33c, consensus 45c 11 Nov
Recommendations	Targa Resources price target raised to $91 from $87 at Mizuho » 06:42 08/09/22 08/09 06:42 08/09/22 06:42 TRGP Targa Resources $65.03 / +1.275 (+2.00%) Mizuho analyst Gabriel… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in 9 minutes Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings On The Fly TRGP Targa Resources $65.03 / +1.275 (+2.00%) 06/16/22 Targa Resources expects Lucid acquisition to be accretive to cash flow per share 06/16/22 Targa Resources now sees FY22 adjusted EBITDA $2.68B-$2.78B 06/16/22 Targa Resources to acquire Lucid Energy for $3.55B 04/21/22 Targa Resources completes acquisition of Southcross Energy Operating LLC TRGP Targa Resources $65.03 / +1.275 (+2.00%) 07/20/22 Barclays Targa Resources price target lowered to $87 from $92 at Barclays 07/12/22 RBC Capital Targa Resources price target raised to $100 from $90 at RBC Capital 05/02/22 Truist Targa Resources assumed with a Buy at Truist 04/26/22 Morgan Stanley Targa Resources price target raised to $103 from $74 at Morgan Stanley TRGP Targa Resources $65.03 / +1.275 (+2.00%) 08/04/22 Targa Resources raises 2022 adj EBITDA view to $2.85B-$2.95B from $2.68B-$2.78B 08/04/22 Targa Resources reports Q2 revenue $6.06B, consensus $5.82B 05/05/22 Targa Resources reports Q1 revenue $4.96B, consensus $4.87B 02/24/22 Targa Resources revenue $5.44B, consensus $4.19B TRGP Targa Resources $65.03 / +1.275 (+2.00%) 06/16/22 Fly Intel: After-Hours Movers
Earnings	Vivid Seats reports Q2 rvenue $147.7M, consensus $125.4M » 06:42 08/09/22 08/09 06:42 08/09/22 06:42 SEAT Vivid Seats $8.70 / +0.18 (+2.11%) Reports Q2 Adjusted… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings Events SEAT Vivid Seats $8.70 / +0.18 (+2.11%) 07/27/22 Vivid Seats, Rolling Stone announce a multi-faceted partnership 06/30/22 Vivid Seats announces expiration, results of exchange offer 06/16/22 Vivid Seats to join Russell 2000, Russell 3000 Indexes 05/26/22 Vivid Seats board authorizes $40M share repurchase program SEAT Vivid Seats $8.70 / +0.18 (+2.11%) 07/14/22 Piper Sandler Vivid Seats initiated with a Neutral at Piper Sandler 07/07/22 Citi Vivid Seats price target lowered to $12 from $14 at Citi 05/10/22 Raymond James Vivid Seats price target lowered to $11 from $17 at Raymond James 03/11/22 Benchmark Vivid Seats price target lowered to $17 from $19 at Benchmark SEAT Vivid Seats $8.70 / +0.18 (+2.11%) 05/10/22 Vivid Seats raises FY22 revenue view to $520.0M-$555.0M from $510.0M-$550.0M 05/10/22 Vivid Seats reports Q1 revenue $130.8M, consensus $113.83M 03/10/22 Vivid Seats sees 2022 revenue $510M-$550M, consensus $554.44M 03/10/22 Vivid Seats reports Q4 revenue $163.9M, consensus $139.54M 08/08/22 42nd Annual Global I Growth Conference 09/08/22 Consumer/Media/Entertainment Conference 08:30 Today Vivid Seats - SEAT
Recommendations	Pinnacle West price target raised to $77 from $76 at Mizuho » 06:41 08/09/22 08/09 06:41 08/09/22 06:41 PNW Pinnacle West $75.60 / +0.215 (+0.29%) Mizuho analyst Anthony… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in 9 minutes Get Free Trial ShowHide Related Items >><< Street Research Earnings PNW Pinnacle West $75.60 / +0.215 (+0.29%) 07/18/22 Barclays Pinnacle West price target lowered to $68 from $78 at Barclays 06/30/22 UBS Pinnacle West price target lowered to $67 from $74 at UBS 04/25/22 Credit Suisse Pinnacle West initiated with an Underperform at Credit Suisse 04/19/22 Barclays Pinnacle West downgraded to Underweight from Equal Weight at Barclays PNW Pinnacle West $75.60 / +0.215 (+0.29%) 08/03/22 Pinnacle West backs FY22 EPS view of $3.90-$4.10, consensus $4.02 08/03/22 Pinnacle West reports Q2 EPS $1.45, consensus $1.32 05/04/22 Pinnacle West sees FY22 EPS $3.90-$4.10, consensus $4.02 05/04/22 Pinnacle West reports Q1 EPS 15c, consensus 6c

Events

Earnings calls, analyst events, roadshows and more

XYF
Today at 07:00

X Financial - XYF Conference Calls
NE
Today at 08:00

Noble Corp. - NE Conference Calls
ESAB
Today at 08:00

ESAB - ESAB Conference Calls
BHC
Today at 08:00

Bausch Health - BHC Conference Calls
BLDE
Today at 08:00

Blade Air Mobility - BLDE Conference Calls
LMND
Today at 08:00

Lemonade - LMND Conference Calls
AXSM
Today at 08:00

Axsome Therapeutics - AXSM Conference Calls
KPLT
Today at 08:00

Katapult - KPLT Conference Calls
KLTR
Today at 08:00

Kaltura - KLTR Conference Calls
SDC
Today at 08:00

SmileDirectClub - SDC Conference Calls

View All Events »

1 of

Syndicate

This week’s upcoming IPOs and secondary offerings

Priced
Not Priced

Mon	BRBR X BRBR BellRing Brands Spot Secondary Managers: JPMorgan, Barclays, Citi, Goldman Sachs & Morgan Stanley Priced at: $23.50 14.8M Shares Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial NUZE X NUZE NuZee Spot Secondary Managers: Maxim Priced at: $0.82 4.2M Shares PFLT X PFLT PennantPark Floating Rate Spot Secondary Managers: Morgan Stanley, Goldman Sachs, JPMorgan, Keefe Bruyette, RBC Capital & Truist Priced at: $12.40 4M Shares Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial
Tues	No deals
Wed	No deals
Thurs	No deals
Fri	No deals

Mon	AYTU X AYTU Aytu BioPharma Spot Secondary Managers: Cantor Fitzgerald & Canaccord $0.59 MDNA X MDNA Medicenna Therapeutics Spot Secondary Managers: Guggenheim, Bloom Burton Securities $1.45-1.55
Tues	CINC X CINC CinCor Pharma Secondary Managers: Goldman Sachs, Morgan Stanley, Jefferies & Piper Sandler $35.00 6M Shares KRTX X KRTX Karuna Therapeutics Secondary Managers: Goldman Sachs & JPMorgan, Jefferies $241.19 Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial
Wed	FRZA X FRZA Forza X1 IPO Managers: ThinkEquity $5.00 3M Shares PTLO X PTLO Portillo's Secondary Managers: Jefferies & Morgan Stanley, BofA, Piper Sandler $28.44 8M Shares SOVO X SOVO Sovos Brands Secondary Managers: JPMorgan & Goldman Sachs, BofA, Credit Suisse, Barclays, UBS, Cowen, Piper Sandler, Stifel, William Blair, Telsey Advisory, Drexel Hamilton, Loop Capital $16.01 8.5M Shares
Thurs	No deals
Fri	No deals

View All Syndicate Announcements »

Shutterstock joins the board of the News Media Coalition

OTHER BREAKING NEWS FROM THE FLY

Get Full Fly Access